Product correctly added to cart.

discount label
No image
View 3D

EDQM - European Pharmacopoeia logo

Solifenacin for system suitability CRS

CAS: 242478-38-2

Ref. 41-Y0001743

2.52mg
115.00 €
Estimated delivery in United States, on Thursday 5 Dec 2024

Product Information

Name:
Solifenacin for system suitability CRS
Synonyms:
  • (3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate butanedioate (1:1)
  • 1-Azabicyclo[2.2.2]octan-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate butanedioic acid
  • 1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
  • 1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate butanedioate (1:1)
  • 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S)-, butanedioate (1:1)
  • Butanedioic acid, compd. with (1S)-(3R)-1-azabicyclo[2.2.2]oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1)
  • Vesicare
  • Vesikur
  • Ym 67905
  • Solifenacin succinate
  • See more synonyms
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
EDQM - European Pharmacopoeia
Long term storage:
Notes:

Chemical properties

Molecular weight:
480.5528
Formula:
C27H32N2O6
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 41-Y0001743 Solifenacin for system suitability CRS

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".